Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Epidemiology of neurologically disabling disorders.
Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.
Metallic gold beads in hyaluronic acid: a novel form of gold-based immunosuppression? Investigations of the immunosuppressive effects of metallic gold on cultured J774 macrophages and on neuronal gene expression in experimental autoimmune encephalomyeliti
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population.
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis.
Stem cell therapy independent of stemness.
Neuropathic pain: diagnosis and treatment.
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases.
Systematic framework to evaluate the status of physical activity research for persons with multiple sclerosis.
Immune regulation of multiple sclerosis by CD8+ T cells.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis-Reply.
Low levels of vitamin d in neuromyelitis optica spectrum disorder: association with disease disability.
Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4.
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome.
Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
The influence of glutamatergic receptor antagonists on biochemical and ultrastructural changes in myelin membranes of rats subjected to experimental autoimmune encephalomyelitis.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Optimizing treatment success in multiple sclerosis.
Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal.
Distinct and Atypical Intrinsic and Extrinsic Cell Death Pathways between Photoreceptor Cell Types upon Specific Ablation of Ranbp2 in Cone Photoreceptors.
Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis.

Pages